Mylan launches generic Brevibloc heart injection

Mylan launches generic Brevibloc heart injection

Source: 
Drug Delivery Business News
snippet: 

Mylan (NSDQ:MYL) said today that it launched a generic version of Baxter‘s (NYSE:BAX) Brevibloc heart drug in the U.S.

The company’s injectable product, esmolol hydrochloride in sodium chloride, will be offered in single-dose plastic bags, according to Mylan.